Back
Intellia Therapeutics Vs. John Wiley & Sons Industry Stock Comparison
Sell
43
NTLA
Intellia Therapeutics
Last Price:
25.18
Seasonality Move:
26.13%
Sell
50
WLY
John Wiley & Sons
Last Price:
39.98
Seasonality Move:
1.66%
Sell
43
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy, Sell or Hold?
- The current Intellia Therapeutics [NTLA] share price is $25.17. The Score for NTLA is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- NTLA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
John Wiley & Sons (WLY)
is a Sell
Is John Wiley & Sons a Buy, Sell or Hold?
- The current John Wiley & Sons [WLY] share price is $39.98. The Score for WLY is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- WLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NTLA Stock Price Chart
What is Intellia Therapeutics's stock price today?
-
The Intellia Therapeutics share price today is $25.17
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NTLA is experiencing slight selling pressure.
WLY Stock Price Chart
What is John Wiley & Sons's stock price today?
-
The John Wiley & Sons share price today is $39.98
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WLY is experiencing buying pressure, which is a positive indicator for future bullish movement.
NTLA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.24 | Buy |
Relative Strength Index (14 RSI): | 56.29 | Buy |
Chaikin Money Flow: | -35537 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.83 - 25.93) | Buy |
Bollinger Bands (100): | (22.82 - 28.4) | Sell |
WLY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.31 | Buy |
Relative Strength Index (14 RSI): | 64.17 | Buy |
Chaikin Money Flow: | 218284 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (35.95 - 38.91) | Buy |
Bollinger Bands (100): | (34.48 - 38.58) | Buy |
NTLA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.35 | Buy |
20-day SMA: | 23.99 | Buy |
50-day SMA: | 23.65 | Buy |
200-day SMA: | 27.77 | Sell |
8-day EMA: | 24.64 | Buy |
20-day EMA: | 24.18 | Buy |
50-day EMA: | 24.41 | Buy |
200-day EMA: | 28.7 | Sell |
WLY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.53 | Buy |
20-day SMA: | 37.19 | Buy |
50-day SMA: | 37.74 | Buy |
200-day SMA: | 34.52 | Buy |
8-day EMA: | 38.3 | Buy |
20-day EMA: | 37.61 | Buy |
50-day EMA: | 37.35 | Buy |
200-day EMA: | 36.04 | Buy |
Intellia Therapeutics Earnings Growth & NTLA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.00 per share, an increase this year of $0.28 per share, and a decrease next year of $0.38 per share.
John Wiley & Sons Earnings Growth & WLY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.51 per share, a decrease next quarter of $0.23 per share, a decrease this year of $1.00 per share, and an increase next year of $1.00 per share.
Intellia Therapeutics Technical Analysis
Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
John Wiley & Sons Technical Analysis
Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |